C2N Diagnostics
Developing innovative diagnostics for Alzheimer's disease and related neurodegenerative conditions.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD82—123m (Dealroom.co estimates Mar 2024.)
St. Louis Missouri (HQ)
Authorizing premium user...